(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...
Property giant Megaworld Corp. is set to reinvest over P5 billion raised from block sales of MREIT Inc. shares over the past ...
Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...
In the United States' health care system, you can spend weeks or months anticipating a doctor's appointment, plus a few minutes or hours in the waiting room when the day comes. In ...
A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood cancers. By Apoorva Mandavilli For about a decade, scientists have had ...
Tens of thousands of cancer patients across England are set to benefit from a new rapid immunotherapy injection now being rolled out by the NHS, which can be administered in as little as 60 seconds.
If you’re anything like me, you’ve likely learned to approach new beauty launches with a healthy dose of skepticism—especially those that promise overnight results or claim to replicate pricey ...
If your first day of chemo is coming up, you can prepare in some practical ways. You might be wondering what to bring along, how the treatment will feel, how long it will take, or if you’ll need a ...
A young immigrant woman falls for a troubled U.S. soldier in this sensitive and sweetly melancholic drama. Sebiye Behtiyar, left, with Fred Hechinger in “Preparation for the Next Life.” By Jeannette ...
Bing Liu makes his fiction debut with a superbly acted drama chronicling the unstable relationship between an undocumented woman and a U.S. Army vet with mental health issues. The spark between two ...
‘Preparation for the Next Life’ Review: ‘Minding the Gap’ Director Bing Liu’s First Narrative Feature Is a Haunting Outsider Love Story Fred Hechinger and newcomer Sebiye Behtiyar star as two people ...
The exact mechanism responsible for infusion-related reactions (IRRs) after monoclonal antibody (mAb) therapy is unclear. It is also unknown before treatment which patient will develop IRRs. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results